chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 83.0
Sex: F
Vaccine: PNC20
Symptoms: Swelling of eyelid
Clinical narrative: both eyelids  swollen
Age: 2.0
Sex: F
Vaccine: COVID19
Symptoms: Product preparation issue
Clinical narrative: The Pfizer (maroon cap) vaccine was administered to this patient who is 2 years old. However, the nurse used the incorrect volume of diluent to reconstitute the vaccine vial. 1.3ml of sodium chloride was used for reconstitution instead of the required 2.2mL for the maroon cap vaccine. The patient was given the vaccine and monitored during the observational phase. No adverse event was seen.  Contacted Pfizer representative for more information regarding future vaccination schedule. Pfizer representative stated that the patient should just continue the vaccination schedule normally as indicated by the CDC guidelines.
Age: 3.0
Sex: M
Vaccine: COVID19
Symptoms: Product preparation issue
Clinical narrative: The Pfizer (maroon cap) vaccine was administered to this patient who is 3 years old. However, the nurse used the incorrect volume of diluent to reconstitute the vaccine vial. 1.3ml of sodium chloride was used for reconstitution instead of the required 2.2mL for the maroon cap vaccine. The patient was given the vaccine and monitored during the observational phase. No adverse event was seen.  Contacted Pfizer representative for more information regarding future vaccination schedule. Pfizer representative stated that the patient should just continue the vaccination schedule normally as indicated by the CDC guidelines.
Age: 4.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product preparation error
Clinical narrative: The Pfizer (maroon cap) vaccine was administered to this patient who is 4 years old. However, the nurse used the incorrect volume of diluent to reconstitute the vaccine vial. 1.3ml of sodium chloride was used for reconstitution instead of the required 2.2mL for the maroon cap vaccine. The patient was given the vaccine and monitored during the observational phase. No adverse event was seen.  Contacted Pfizer representative for more information regarding future vaccination schedule. Pfizer representative stated that the patient should just continue the vaccination schedule normally as indicated by the CDC guidelines.
Age: 3.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product preparation error, Product preparation issue
Clinical narrative: The Pfizer (maroon cap) vaccine was administered to this patient who is 3 years old. However, the nurse used the incorrect volume of diluent to reconstitute the vaccine vial. 1.3ml of sodium chloride was used for reconstitution instead of the required 2.2mL for the maroon cap vaccine. The patient was given the vaccine and monitored during the observational phase. No adverse event was seen. Contacted Pfizer representative for more information regarding future vaccination schedule. Pfizer representative stated that the patient should just continue the vaccination schedule normally as indicated by the CDC guidelines.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Contusion, Ecchymosis
Clinical narrative: Patient stated she developed large area of bruising. Estimates 3-inch diameter ecchymosis right wrist and dorsal aspect of right hand, immediately after vaccination.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Cardiomegaly, Hypoaesthesia, Thrombosis, Transfusion
Clinical narrative: Numbness of left arm going into left side of face. Since resolved May of 2022 had blood clots and heart swelling, and multiple blood transusions at Hospital.
Sex: M
Vaccine: RV5
Symptoms: Abnormal faeces, Haematochezia, Infant irritability, Intussusception, Mucous stools
Clinical narrative: He developed increased fussiness and abnormal stools with blood/mucus.  Was instructed to go to the ED.  He went to  ED and had an US which showed "Self resolving intussusceptions noted during the exam, this is likely intermittent small bowel intussusception. "
Sex: M
Vaccine: RV5
Symptoms: Ultrasound scan
Clinical narrative: He developed increased fussiness and abnormal stools with blood/mucus.  Was instructed to go to the ED.  He went to  ED and had an US which showed "Self resolving intussusceptions noted during the exam, this is likely intermittent small bowel intussusception. "
Age: 4.0
Sex: M
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: The Pfizer (orange cap) vaccine was administered to this patient who is 4 years old. The nurse accidentally administer this vaccine to the patient even though he has not reach the age limit required for the orange cap vaccine (5-11 years old). The patient was given the vaccine and monitored during the observational phase. No adverse event was seen.  Contacted representative for more information regarding future vaccination schedule. representative stated that the patient should just continue the vaccination schedule normally as indicated by the CDC guidelines.
Age: 4.0
Sex: M
Vaccine: DTAP
Symptoms: Wrong product administered
Clinical narrative: The patient was given the wrong vaccine. DTaP was drawn up and administered to the patient. The patient was supposed to get combination PediaRix as a third dose to finish off the series. Patient was notified and asked to come in to receive additional vaccines. Patient did receive missing vaccines (Hep A, Hep B, IPV) on same day.
Age: 22.0
Sex: F
Vaccine: TDAP
Symptoms: Wrong product administered
Clinical narrative: Provider ordered HPV vaccine for this patient. Patient was inadvertently given Tdap vaccine by medical assistance. Once mistake was caught, notified provider and patient. Patient was stable and will come back for future visit to receive the correct vaccine.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure increased, Heart rate decreased, Heart rate irregular, Pruritus
Clinical narrative: Patient came in today to get preventive vaccines.  While discussing vaccination, patient states her blood pressure went up, had low pulse rate, irregular heart beat, occasional itchiness on injection arm since 2nd dose of pfizer in 1/2022.
Age: 46.0
Sex: M
Vaccine: SMALLMNK
Symptoms: Anogenital warts, Cryotherapy
Clinical narrative: Possible re-activation of latent HPV.  Clinical manifestation of genital warts two days after Jynneos administration
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue
Clinical narrative: This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. An 82-year-old male patient received BNT162b2 (BNT162B2), on 04Feb2021 as dose 2, single (Batch/Lot number: unknown) at the age of 81 years for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: BNT162b2 (DOSE:1, SINGLE; Lot number: Unknown), administration date: 14Jan2021, when the patient was 81-year-old, for COVID-19 immunisation, reaction(s): "headache", "Fatigue", "Asthenia". The following information was reported: FATIGUE (non-serious), outcome "unknown", described as "made me tired for few days". Additional information: Patient reported that he had two Pfizer vaccine shots about in 14Jan2021 and 04Feb2021 and he was tired when he had that vaccines. It made him tired for few days. He did not get a booster because he heard those boosters might cause some problems.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received. Sender's Comments: Linked Report(s) : PFIZER INC-2021073896 Same patient/product, different dose;
Age: 33.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Acne, Alopecia, Asthenia, Blood test normal, Body temperature increased
Clinical narrative: major hair loss; started with super dry hair and skin; started with super dry hair and skin; had Major Insomnia for months last summer (biological. Not emotional.); Much Weaker than normal when working out; Short of breath overall (this continues until today); 10-15lb weight gain without any diet or physical activity change and a lot of new cellulite on thighs and bum; dizziness especially when getting up; Increased body heat and sweating; Increased body heat and sweating; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 33-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 22Apr2021 as dose 2, single (Lot number: EW 0164) at the age of 33 years for covid-19 immunisation. The patient's relevant medical history included: "Don't smoke or drink" (unspecified if ongoing). The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose Number: 1, Batch/Lot No: ER 8733), for COVID-19 immunization.  The following information was reported: WEIGHT INCREASED (non-serious) with onset 22Apr2021, outcome "not recovered", described as "10-15lb weight gain without any diet or physical activity change and a lot of new cellulite on thighs and bum"; BODY TEMPERATURE INCREASED (non-serious), HYPERHIDROSIS (non-serious) all with onset 22Apr2021, outcome "not recovered" and all described as "Increased body heat and sweating"; ASTHENIA (non-serious) with onset 22Apr2021, outcome "not recovered", described as "Much Weaker than normal when working out"; DYSPNOEA (non-serious) with onset 22Apr2021, outcome "not recovered", described as "Short of breath overall (this continues until today)"; DIZZINESS (non-serious) with onset 22Apr2021, outcome "not recovered", described as "dizziness especially when getting up"; INSOMNIA (non-serious) with onset 22Apr2021, outcome "recovered", described as "had Major Insomnia for months last summer (biological. Not emotional.)"; ALOPECIA (non-serious) with onset Jun2021, outcome "not recovered", described as "major hair loss"; HAIR TEXTURE ABNORMAL (non-serious), DRY SKIN (non-serious) all with onset Jun2021, outcome "not recovered" and all described as "started with super dry hair and skin". The events "dizziness especially when getting up", "increased body heat and sweating", "major hair loss", "started with super dry hair and skin", "had major insomnia for months last summer (biological. not emotional.)", "much weaker than normal when working out", "short of breath overall (this continues until today)" and "10-15lb weight gain without any diet or physical activity change and a lot of new cellulite on thighs and bum" required physician office visit and emergency room visit. Relevant laboratory tests and procedures are available in the appropriate section.
Age: 33.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Dizziness, Dizziness postural, Dry skin, Dysmenorrhoea, Dyspnoea
Clinical narrative: major hair loss; started with super dry hair and skin; started with super dry hair and skin; had Major Insomnia for months last summer (biological. Not emotional.); Much Weaker than normal when working out; Short of breath overall (this continues until today); 10-15lb weight gain without any diet or physical activity change and a lot of new cellulite on thighs and bum; dizziness especially when getting up; Increased body heat and sweating; Increased body heat and sweating; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 33-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 22Apr2021 as dose 2, single (Lot number: EW 0164) at the age of 33 years for covid-19 immunisation. The patient's relevant medical history included: "Don't smoke or drink" (unspecified if ongoing). The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose Number: 1, Batch/Lot No: ER 8733), for COVID-19 immunization.  The following information was reported: WEIGHT INCREASED (non-serious) with onset 22Apr2021, outcome "not recovered", described as "10-15lb weight gain without any diet or physical activity change and a lot of new cellulite on thighs and bum"; BODY TEMPERATURE INCREASED (non-serious), HYPERHIDROSIS (non-serious) all with onset 22Apr2021, outcome "not recovered" and all described as "Increased body heat and sweating"; ASTHENIA (non-serious) with onset 22Apr2021, outcome "not recovered", described as "Much Weaker than normal when working out"; DYSPNOEA (non-serious) with onset 22Apr2021, outcome "not recovered", described as "Short of breath overall (this continues until today)"; DIZZINESS (non-serious) with onset 22Apr2021, outcome "not recovered", described as "dizziness especially when getting up"; INSOMNIA (non-serious) with onset 22Apr2021, outcome "recovered", described as "had Major Insomnia for months last summer (biological. Not emotional.)"; ALOPECIA (non-serious) with onset Jun2021, outcome "not recovered", described as "major hair loss"; HAIR TEXTURE ABNORMAL (non-serious), DRY SKIN (non-serious) all with onset Jun2021, outcome "not recovered" and all described as "started with super dry hair and skin". The events "dizziness especially when getting up", "increased body heat and sweating", "major hair loss", "started with super dry hair and skin", "had major insomnia for months last summer (biological. not emotional.)", "much weaker than normal when working out", "short of breath overall (this continues until today)" and "10-15lb weight gain without any diet or physical activity change and a lot of new cellulite on thighs and bum" required physician office visit and emergency room visit. Relevant laboratory tests and procedures are available in the appropriate section.
Age: 33.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Electric shock sensation, Exercise tolerance decreased, Feeling abnormal, Hair texture abnormal, Headache
Clinical narrative: major hair loss; started with super dry hair and skin; started with super dry hair and skin; had Major Insomnia for months last summer (biological. Not emotional.); Much Weaker than normal when working out; Short of breath overall (this continues until today); 10-15lb weight gain without any diet or physical activity change and a lot of new cellulite on thighs and bum; dizziness especially when getting up; Increased body heat and sweating; Increased body heat and sweating; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 33-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 22Apr2021 as dose 2, single (Lot number: EW 0164) at the age of 33 years for covid-19 immunisation. The patient's relevant medical history included: "Don't smoke or drink" (unspecified if ongoing). The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose Number: 1, Batch/Lot No: ER 8733), for COVID-19 immunization.  The following information was reported: WEIGHT INCREASED (non-serious) with onset 22Apr2021, outcome "not recovered", described as "10-15lb weight gain without any diet or physical activity change and a lot of new cellulite on thighs and bum"; BODY TEMPERATURE INCREASED (non-serious), HYPERHIDROSIS (non-serious) all with onset 22Apr2021, outcome "not recovered" and all described as "Increased body heat and sweating"; ASTHENIA (non-serious) with onset 22Apr2021, outcome "not recovered", described as "Much Weaker than normal when working out"; DYSPNOEA (non-serious) with onset 22Apr2021, outcome "not recovered", described as "Short of breath overall (this continues until today)"; DIZZINESS (non-serious) with onset 22Apr2021, outcome "not recovered", described as "dizziness especially when getting up"; INSOMNIA (non-serious) with onset 22Apr2021, outcome "recovered", described as "had Major Insomnia for months last summer (biological. Not emotional.)"; ALOPECIA (non-serious) with onset Jun2021, outcome "not recovered", described as "major hair loss"; HAIR TEXTURE ABNORMAL (non-serious), DRY SKIN (non-serious) all with onset Jun2021, outcome "not recovered" and all described as "started with super dry hair and skin". The events "dizziness especially when getting up", "increased body heat and sweating", "major hair loss", "started with super dry hair and skin", "had major insomnia for months last summer (biological. not emotional.)", "much weaker than normal when working out", "short of breath overall (this continues until today)" and "10-15lb weight gain without any diet or physical activity change and a lot of new cellulite on thighs and bum" required physician office visit and emergency room visit. Relevant laboratory tests and procedures are available in the appropriate section.
Age: 33.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Hyperhidrosis, Insomnia, Laboratory test, Memory impairment, Rash
Clinical narrative: major hair loss; started with super dry hair and skin; started with super dry hair and skin; had Major Insomnia for months last summer (biological. Not emotional.); Much Weaker than normal when working out; Short of breath overall (this continues until today); 10-15lb weight gain without any diet or physical activity change and a lot of new cellulite on thighs and bum; dizziness especially when getting up; Increased body heat and sweating; Increased body heat and sweating; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 33-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 22Apr2021 as dose 2, single (Lot number: EW 0164) at the age of 33 years for covid-19 immunisation. The patient's relevant medical history included: "Don't smoke or drink" (unspecified if ongoing). The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose Number: 1, Batch/Lot No: ER 8733), for COVID-19 immunization.  The following information was reported: WEIGHT INCREASED (non-serious) with onset 22Apr2021, outcome "not recovered", described as "10-15lb weight gain without any diet or physical activity change and a lot of new cellulite on thighs and bum"; BODY TEMPERATURE INCREASED (non-serious), HYPERHIDROSIS (non-serious) all with onset 22Apr2021, outcome "not recovered" and all described as "Increased body heat and sweating"; ASTHENIA (non-serious) with onset 22Apr2021, outcome "not recovered", described as "Much Weaker than normal when working out"; DYSPNOEA (non-serious) with onset 22Apr2021, outcome "not recovered", described as "Short of breath overall (this continues until today)"; DIZZINESS (non-serious) with onset 22Apr2021, outcome "not recovered", described as "dizziness especially when getting up"; INSOMNIA (non-serious) with onset 22Apr2021, outcome "recovered", described as "had Major Insomnia for months last summer (biological. Not emotional.)"; ALOPECIA (non-serious) with onset Jun2021, outcome "not recovered", described as "major hair loss"; HAIR TEXTURE ABNORMAL (non-serious), DRY SKIN (non-serious) all with onset Jun2021, outcome "not recovered" and all described as "started with super dry hair and skin". The events "dizziness especially when getting up", "increased body heat and sweating", "major hair loss", "started with super dry hair and skin", "had major insomnia for months last summer (biological. not emotional.)", "much weaker than normal when working out", "short of breath overall (this continues until today)" and "10-15lb weight gain without any diet or physical activity change and a lot of new cellulite on thighs and bum" required physician office visit and emergency room visit. Relevant laboratory tests and procedures are available in the appropriate section.
Age: 33.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Thyroid function test normal, Weight increased
Clinical narrative: major hair loss; started with super dry hair and skin; started with super dry hair and skin; had Major Insomnia for months last summer (biological. Not emotional.); Much Weaker than normal when working out; Short of breath overall (this continues until today); 10-15lb weight gain without any diet or physical activity change and a lot of new cellulite on thighs and bum; dizziness especially when getting up; Increased body heat and sweating; Increased body heat and sweating; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 33-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 22Apr2021 as dose 2, single (Lot number: EW 0164) at the age of 33 years for covid-19 immunisation. The patient's relevant medical history included: "Don't smoke or drink" (unspecified if ongoing). The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose Number: 1, Batch/Lot No: ER 8733), for COVID-19 immunization.  The following information was reported: WEIGHT INCREASED (non-serious) with onset 22Apr2021, outcome "not recovered", described as "10-15lb weight gain without any diet or physical activity change and a lot of new cellulite on thighs and bum"; BODY TEMPERATURE INCREASED (non-serious), HYPERHIDROSIS (non-serious) all with onset 22Apr2021, outcome "not recovered" and all described as "Increased body heat and sweating"; ASTHENIA (non-serious) with onset 22Apr2021, outcome "not recovered", described as "Much Weaker than normal when working out"; DYSPNOEA (non-serious) with onset 22Apr2021, outcome "not recovered", described as "Short of breath overall (this continues until today)"; DIZZINESS (non-serious) with onset 22Apr2021, outcome "not recovered", described as "dizziness especially when getting up"; INSOMNIA (non-serious) with onset 22Apr2021, outcome "recovered", described as "had Major Insomnia for months last summer (biological. Not emotional.)"; ALOPECIA (non-serious) with onset Jun2021, outcome "not recovered", described as "major hair loss"; HAIR TEXTURE ABNORMAL (non-serious), DRY SKIN (non-serious) all with onset Jun2021, outcome "not recovered" and all described as "started with super dry hair and skin". The events "dizziness especially when getting up", "increased body heat and sweating", "major hair loss", "started with super dry hair and skin", "had major insomnia for months last summer (biological. not emotional.)", "much weaker than normal when working out", "short of breath overall (this continues until today)" and "10-15lb weight gain without any diet or physical activity change and a lot of new cellulite on thighs and bum" required physician office visit and emergency room visit. Relevant laboratory tests and procedures are available in the appropriate section.
Age: 33.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Alopecia, Asthenia, Body temperature, Body temperature increased, Dizziness
Clinical narrative: major hair loss; started with super dry hair and skin; started with super dry hair and skin; had Major Insomnia for months last summer (biological. Not emotional.); Much Weaker than normal when working out; Short of breath overall (this continues until today); 10-15lb weight gain without any diet or physical activity change and a lot of new cellulite on thighs and bum; dizziness especially when getting up; Increased body heat and sweating; Increased body heat and sweating; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 33-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 22Apr2021 as dose 2, single (Lot number: EW 0164) at the age of 33 years for covid-19 immunisation. The patient's relevant medical history included: "Don't smoke or drink" (unspecified if ongoing). The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose Number: 1, Batch/Lot No: ER 8733), for COVID-19 immunization.  The following information was reported: WEIGHT INCREASED (non-serious) with onset 22Apr2021, outcome "not recovered", described as "10-15lb weight gain without any diet or physical activity change and a lot of new cellulite on thighs and bum"; BODY TEMPERATURE INCREASED (non-serious), HYPERHIDROSIS (non-serious) all with onset 22Apr2021, outcome "not recovered" and all described as "Increased body heat and sweating"; ASTHENIA (non-serious) with onset 22Apr2021, outcome "not recovered", described as "Much Weaker than normal when working out"; DYSPNOEA (non-serious) with onset 22Apr2021, outcome "not recovered", described as "Short of breath overall (this continues until today)"; DIZZINESS (non-serious) with onset 22Apr2021, outcome "not recovered", described as "dizziness especially when getting up"; INSOMNIA (non-serious) with onset 22Apr2021, outcome "recovered", described as "had Major Insomnia for months last summer (biological. Not emotional.)"; ALOPECIA (non-serious) with onset Jun2021, outcome "not recovered", described as "major hair loss"; HAIR TEXTURE ABNORMAL (non-serious), DRY SKIN (non-serious) all with onset Jun2021, outcome "not recovered" and all described as "started with super dry hair and skin". The events "dizziness especially when getting up", "increased body heat and sweating", "major hair loss", "started with super dry hair and skin", "had major insomnia for months last summer (biological. not emotional.)", "much weaker than normal when working out", "short of breath overall (this continues until today)" and "10-15lb weight gain without any diet or physical activity change and a lot of new cellulite on thighs and bum" required physician office visit and emergency room visit. Relevant laboratory tests and procedures are available in the appropriate section.
Age: 33.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Dry skin, Dyspnoea, Hair texture abnormal, Hyperhidrosis, Insomnia
Clinical narrative: major hair loss; started with super dry hair and skin; started with super dry hair and skin; had Major Insomnia for months last summer (biological. Not emotional.); Much Weaker than normal when working out; Short of breath overall (this continues until today); 10-15lb weight gain without any diet or physical activity change and a lot of new cellulite on thighs and bum; dizziness especially when getting up; Increased body heat and sweating; Increased body heat and sweating; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 33-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 22Apr2021 as dose 2, single (Lot number: EW 0164) at the age of 33 years for covid-19 immunisation. The patient's relevant medical history included: "Don't smoke or drink" (unspecified if ongoing). The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose Number: 1, Batch/Lot No: ER 8733), for COVID-19 immunization.  The following information was reported: WEIGHT INCREASED (non-serious) with onset 22Apr2021, outcome "not recovered", described as "10-15lb weight gain without any diet or physical activity change and a lot of new cellulite on thighs and bum"; BODY TEMPERATURE INCREASED (non-serious), HYPERHIDROSIS (non-serious) all with onset 22Apr2021, outcome "not recovered" and all described as "Increased body heat and sweating"; ASTHENIA (non-serious) with onset 22Apr2021, outcome "not recovered", described as "Much Weaker than normal when working out"; DYSPNOEA (non-serious) with onset 22Apr2021, outcome "not recovered", described as "Short of breath overall (this continues until today)"; DIZZINESS (non-serious) with onset 22Apr2021, outcome "not recovered", described as "dizziness especially when getting up"; INSOMNIA (non-serious) with onset 22Apr2021, outcome "recovered", described as "had Major Insomnia for months last summer (biological. Not emotional.)"; ALOPECIA (non-serious) with onset Jun2021, outcome "not recovered", described as "major hair loss"; HAIR TEXTURE ABNORMAL (non-serious), DRY SKIN (non-serious) all with onset Jun2021, outcome "not recovered" and all described as "started with super dry hair and skin". The events "dizziness especially when getting up", "increased body heat and sweating", "major hair loss", "started with super dry hair and skin", "had major insomnia for months last summer (biological. not emotional.)", "much weaker than normal when working out", "short of breath overall (this continues until today)" and "10-15lb weight gain without any diet or physical activity change and a lot of new cellulite on thighs and bum" required physician office visit and emergency room visit. Relevant laboratory tests and procedures are available in the appropriate section.
Age: 33.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Weight, Weight increased
Clinical narrative: major hair loss; started with super dry hair and skin; started with super dry hair and skin; had Major Insomnia for months last summer (biological. Not emotional.); Much Weaker than normal when working out; Short of breath overall (this continues until today); 10-15lb weight gain without any diet or physical activity change and a lot of new cellulite on thighs and bum; dizziness especially when getting up; Increased body heat and sweating; Increased body heat and sweating; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 33-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 22Apr2021 as dose 2, single (Lot number: EW 0164) at the age of 33 years for covid-19 immunisation. The patient's relevant medical history included: "Don't smoke or drink" (unspecified if ongoing). The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose Number: 1, Batch/Lot No: ER 8733), for COVID-19 immunization.  The following information was reported: WEIGHT INCREASED (non-serious) with onset 22Apr2021, outcome "not recovered", described as "10-15lb weight gain without any diet or physical activity change and a lot of new cellulite on thighs and bum"; BODY TEMPERATURE INCREASED (non-serious), HYPERHIDROSIS (non-serious) all with onset 22Apr2021, outcome "not recovered" and all described as "Increased body heat and sweating"; ASTHENIA (non-serious) with onset 22Apr2021, outcome "not recovered", described as "Much Weaker than normal when working out"; DYSPNOEA (non-serious) with onset 22Apr2021, outcome "not recovered", described as "Short of breath overall (this continues until today)"; DIZZINESS (non-serious) with onset 22Apr2021, outcome "not recovered", described as "dizziness especially when getting up"; INSOMNIA (non-serious) with onset 22Apr2021, outcome "recovered", described as "had Major Insomnia for months last summer (biological. Not emotional.)"; ALOPECIA (non-serious) with onset Jun2021, outcome "not recovered", described as "major hair loss"; HAIR TEXTURE ABNORMAL (non-serious), DRY SKIN (non-serious) all with onset Jun2021, outcome "not recovered" and all described as "started with super dry hair and skin". The events "dizziness especially when getting up", "increased body heat and sweating", "major hair loss", "started with super dry hair and skin", "had major insomnia for months last summer (biological. not emotional.)", "much weaker than normal when working out", "short of breath overall (this continues until today)" and "10-15lb weight gain without any diet or physical activity change and a lot of new cellulite on thighs and bum" required physician office visit and emergency room visit. Relevant laboratory tests and procedures are available in the appropriate section.
Age: 13.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Blood test abnormal, Coagulation test abnormal, Petechiae, Platelet count decreased, Rash macular
Clinical narrative: He developed ITP; depressed; He is always tired, depressed, lazy easily has desire a result of shot; This doctors want to remove his spleen; lazy easily has desire a result of shot; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from legal division. The reporter is the parent.  A 13-year-old male patient received BNT162b2 (BNT162B2), on 07Jun2021 as dose number unknown, single (Batch/Lot number: unknown) at the age of 13 years for COVID-19 immunization. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: IMMUNE THROMBOCYTOPENIA (hospitalization), outcome "unknown", described as "He developed ITP"; DEPRESSION (hospitalization), outcome "unknown", described as "depressed"; FATIGUE (hospitalization), outcome "unknown", described as "He is always tired, depressed, lazy easily has desire a result of shot"; SPLEEN DISORDER (hospitalization), outcome "unknown", described as "This doctors want to remove his spleen"; LAZINESS (hospitalization), outcome "unknown", described as "lazy easily has desire a result of shot". The patient underwent the following laboratory tests and procedures: Immune thrombocytopenia: He no longer produces platelets, notes: Soon after he developed ITP.  Clinical course: It was reported that the patient has suffered hospital and medical expenses, among others. The patient got the COVID Pfizer vaccine on 07Jun2021. Soon after, he developed ITP. He no longer produces platelets. He was always tired, depressed, and "lazy easily has desire" as a result of the shot. The doctors wanted to remove his spleen. He was at perfect health previously. It was further reported that their lives had been turned upside down. The patient was constantly tired, depressed, "discreat", and bruises.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Age: 13.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Depression, Fatigue, Immune thrombocytopenia, Investigation, Laziness
Clinical narrative: He developed ITP; depressed; He is always tired, depressed, lazy easily has desire a result of shot; This doctors want to remove his spleen; lazy easily has desire a result of shot; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from legal division. The reporter is the parent.  A 13-year-old male patient received BNT162b2 (BNT162B2), on 07Jun2021 as dose number unknown, single (Batch/Lot number: unknown) at the age of 13 years for COVID-19 immunization. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: IMMUNE THROMBOCYTOPENIA (hospitalization), outcome "unknown", described as "He developed ITP"; DEPRESSION (hospitalization), outcome "unknown", described as "depressed"; FATIGUE (hospitalization), outcome "unknown", described as "He is always tired, depressed, lazy easily has desire a result of shot"; SPLEEN DISORDER (hospitalization), outcome "unknown", described as "This doctors want to remove his spleen"; LAZINESS (hospitalization), outcome "unknown", described as "lazy easily has desire a result of shot". The patient underwent the following laboratory tests and procedures: Immune thrombocytopenia: He no longer produces platelets, notes: Soon after he developed ITP.  Clinical course: It was reported that the patient has suffered hospital and medical expenses, among others. The patient got the COVID Pfizer vaccine on 07Jun2021. Soon after, he developed ITP. He no longer produces platelets. He was always tired, depressed, and "lazy easily has desire" as a result of the shot. The doctors wanted to remove his spleen. He was at perfect health previously. It was further reported that their lives had been turned upside down. The patient was constantly tired, depressed, "discreat", and bruises.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Age: 13.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Spleen disorder
Clinical narrative: He developed ITP; depressed; He is always tired, depressed, lazy easily has desire a result of shot; This doctors want to remove his spleen; lazy easily has desire a result of shot; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from legal division. The reporter is the parent.  A 13-year-old male patient received BNT162b2 (BNT162B2), on 07Jun2021 as dose number unknown, single (Batch/Lot number: unknown) at the age of 13 years for COVID-19 immunization. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: IMMUNE THROMBOCYTOPENIA (hospitalization), outcome "unknown", described as "He developed ITP"; DEPRESSION (hospitalization), outcome "unknown", described as "depressed"; FATIGUE (hospitalization), outcome "unknown", described as "He is always tired, depressed, lazy easily has desire a result of shot"; SPLEEN DISORDER (hospitalization), outcome "unknown", described as "This doctors want to remove his spleen"; LAZINESS (hospitalization), outcome "unknown", described as "lazy easily has desire a result of shot". The patient underwent the following laboratory tests and procedures: Immune thrombocytopenia: He no longer produces platelets, notes: Soon after he developed ITP.  Clinical course: It was reported that the patient has suffered hospital and medical expenses, among others. The patient got the COVID Pfizer vaccine on 07Jun2021. Soon after, he developed ITP. He no longer produces platelets. He was always tired, depressed, and "lazy easily has desire" as a result of the shot. The doctors wanted to remove his spleen. He was at perfect health previously. It was further reported that their lives had been turned upside down. The patient was constantly tired, depressed, "discreat", and bruises.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Age: 13.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Immune thrombocytopenia, Laboratory test abnormal, Platelet count decreased
Clinical narrative: He developed ITP; depressed; He is always tired, depressed, lazy easily has desire a result of shot; This doctors want to remove his spleen; lazy easily has desire a result of shot; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from legal division. The reporter is the parent.  A 13-year-old male patient received BNT162b2 (BNT162B2), on 07Jun2021 as dose number unknown, single (Batch/Lot number: unknown) at the age of 13 years for COVID-19 immunization. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: IMMUNE THROMBOCYTOPENIA (hospitalization), outcome "unknown", described as "He developed ITP"; DEPRESSION (hospitalization), outcome "unknown", described as "depressed"; FATIGUE (hospitalization), outcome "unknown", described as "He is always tired, depressed, lazy easily has desire a result of shot"; SPLEEN DISORDER (hospitalization), outcome "unknown", described as "This doctors want to remove his spleen"; LAZINESS (hospitalization), outcome "unknown", described as "lazy easily has desire a result of shot". The patient underwent the following laboratory tests and procedures: Immune thrombocytopenia: He no longer produces platelets, notes: Soon after he developed ITP.  Clinical course: It was reported that the patient has suffered hospital and medical expenses, among others. The patient got the COVID Pfizer vaccine on 07Jun2021. Soon after, he developed ITP. He no longer produces platelets. He was always tired, depressed, and "lazy easily has desire" as a result of the shot. The doctors wanted to remove his spleen. He was at perfect health previously. It was further reported that their lives had been turned upside down. The patient was constantly tired, depressed, "discreat", and bruises.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Age: 16.0
Sex: F
Vaccine: HPV9, HPV9, MENB, MNQ
Symptoms: Abdominal pain upper, Cataplexy, Dyspnoea, Loss of consciousness, Musculoskeletal stiffness
Clinical narrative: Had a syncopal event within a minute after the vaccines were administered. She felt lightheaded, passed out on the exam table and had some stiffening movements of her arms and was unconscious for a reported minute. When she awoke she was shaking, very tearful and felt ill to her stomach. She was kept recumbent for about 15 minutes, given a cool cloth for her head; a drink of water and a popsicle. She reported that she had not eaten anything for breakfast or had anything to drink that morning. She continued to feel tired and exhausted. After about 20 minutes was helped to her car, reclined in the seat. After returning home, she was reported to have slept most of the afternoon and hadn't had much to eat by late afternoon. The following morning, she was reported to be feeling better.
Age: 16.0
Sex: F
Vaccine: HPV9, HPV9, MENB, MNQ
Symptoms: Seizure
Clinical narrative: Had a syncopal event within a minute after the vaccines were administered. She felt lightheaded, passed out on the exam table and had some stiffening movements of her arms and was unconscious for a reported minute. When she awoke she was shaking, very tearful and felt ill to her stomach. She was kept recumbent for about 15 minutes, given a cool cloth for her head; a drink of water and a popsicle. She reported that she had not eaten anything for breakfast or had anything to drink that morning. She continued to feel tired and exhausted. After about 20 minutes was helped to her car, reclined in the seat. After returning home, she was reported to have slept most of the afternoon and hadn't had much to eat by late afternoon. The following morning, she was reported to be feeling better.
Age: 16.0
Sex: F
Vaccine: HPV9, HPV9, MENB, MNQ
Symptoms: Dizziness, Loss of consciousness, Syncope
Clinical narrative: Had a syncopal event within a minute after the vaccines were administered. She felt lightheaded, passed out on the exam table and had some stiffening movements of her arms and was unconscious for a reported minute. When she awoke she was shaking, very tearful and felt ill to her stomach. She was kept recumbent for about 15 minutes, given a cool cloth for her head; a drink of water and a popsicle. She reported that she had not eaten anything for breakfast or had anything to drink that morning. She continued to feel tired and exhausted. After about 20 minutes was helped to her car, reclined in the seat. After returning home, she was reported to have slept most of the afternoon and hadn't had much to eat by late afternoon. The following morning, she was reported to be feeling better.
Age: 87.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Acute respiratory failure, COVID-19
Clinical narrative: fully vaccinated, covid positive pt admitted to hospital
Age: 87.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: fully vaccinated, covid positive pt admitted to hospital
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, Cough, Diarrhoea, Fatigue, Headache
Clinical narrative: COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 57-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 21Apr2022 at 18:00 as dose 2, single (Lot number: FK9896), in right arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Hypertension" (unspecified if ongoing); "known allergies: Sulfa" (unspecified if ongoing). Concomitant medication(s) included: LOSARTAN. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Jul2022, outcome "unknown" and all described as "COVID 19 Treatment". Therapeutic measures were taken as a result of drug ineffective, covid-19. Clinical course: the patient received Pfizer Paxlovid as COVID 19 Treatment from 10Jul2022 to 15Jul2022. On 19Jul2022, the patient experienced rebound symptoms of sore throat, runny nose, fatigue and feeling achy after completing 5-day course of Paxlovid and feeling better and mostly symptom-free. The patient recovered from the symptoms on 29Jul2022, no treatment  received for the symptoms.
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Respiratory tract congestion, SARS-CoV-2 test positive, Throat irritation
Clinical narrative: COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 57-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 21Apr2022 at 18:00 as dose 2, single (Lot number: FK9896), in right arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Hypertension" (unspecified if ongoing); "known allergies: Sulfa" (unspecified if ongoing). Concomitant medication(s) included: LOSARTAN. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Jul2022, outcome "unknown" and all described as "COVID 19 Treatment". Therapeutic measures were taken as a result of drug ineffective, covid-19. Clinical course: the patient received Pfizer Paxlovid as COVID 19 Treatment from 10Jul2022 to 15Jul2022. On 19Jul2022, the patient experienced rebound symptoms of sore throat, runny nose, fatigue and feeling achy after completing 5-day course of Paxlovid and feeling better and mostly symptom-free. The patient recovered from the symptoms on 29Jul2022, no treatment  received for the symptoms.
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, Drug ineffective
Clinical narrative: COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 57-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 21Apr2022 at 18:00 as dose 2, single (Lot number: FK9896), in right arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Hypertension" (unspecified if ongoing); "known allergies: Sulfa" (unspecified if ongoing). Concomitant medication(s) included: LOSARTAN. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Jul2022, outcome "unknown" and all described as "COVID 19 Treatment". Therapeutic measures were taken as a result of drug ineffective, covid-19. Clinical course: the patient received Pfizer Paxlovid as COVID 19 Treatment from 10Jul2022 to 15Jul2022. On 19Jul2022, the patient experienced rebound symptoms of sore throat, runny nose, fatigue and feeling achy after completing 5-day course of Paxlovid and feeling better and mostly symptom-free. The patient recovered from the symptoms on 29Jul2022, no treatment  received for the symptoms.
Age: 67.0
Sex: F
Vaccine: FLU4, PNC20, TDAP, VARZOS, FLU4, PNC20, TDAP, VARZOS
Symptoms: Discomfort, Fear, Feeling hot, Gait disturbance, Paraesthesia
Clinical narrative: SPOKE WITH PT 9.35AM @08/12/2022. PTS HAD REACTION AFTER 48 HOURS FEVER/FLU LIKE SX AND ITCHING ALL OVER. AS OF THIS MORNING PTS IS DOING WELL PTS TOOK BENADRYL AND SOME MOTRIN . AS PER PTS SHE WILL FOLLOW UP WITH DOCTOR
Age: 67.0
Sex: F
Vaccine: FLU4, PNC20, TDAP, VARZOS, FLU4, PNC20, TDAP, VARZOS
Symptoms: Pruritus, Skin swelling
Clinical narrative: SPOKE WITH PT 9.35AM @08/12/2022. PTS HAD REACTION AFTER 48 HOURS FEVER/FLU LIKE SX AND ITCHING ALL OVER. AS OF THIS MORNING PTS IS DOING WELL PTS TOOK BENADRYL AND SOME MOTRIN . AS PER PTS SHE WILL FOLLOW UP WITH DOCTOR
Age: 67.0
Sex: F
Vaccine: FLU4, PNC20, TDAP, VARZOS, FLU4, PNC20, TDAP, VARZOS
Symptoms: Influenza like illness, Pruritus, Pyrexia
Clinical narrative: SPOKE WITH PT 9.35AM @08/12/2022. PTS HAD REACTION AFTER 48 HOURS FEVER/FLU LIKE SX AND ITCHING ALL OVER. AS OF THIS MORNING PTS IS DOING WELL PTS TOOK BENADRYL AND SOME MOTRIN . AS PER PTS SHE WILL FOLLOW UP WITH DOCTOR